Journal ArticleDOI
Aging and cancer.
Reads0
Chats0
TLDR
Physicians and oncologists need to be prepared for the projected increase of cancer in older persons and a new subspecialty is evolving: geriatric oncology.Abstract:
The world's population is aging. Older age is associated with an increase in the incidence of cancer, especially cancer of the breast, lung, prostate, and colon. The management of older patients with cancer is biased by the simple fact of their chronologic age. Underscreening, understaging, less aggressive therapy, lack of participation in clinical trials, or no treatment at all reflect this bias. Although an age-related reduction in the physiologic function of many organs occurs with age, these are not contraindications to treatment with surgery, radiation therapy, or chemotherapy. Chronologic age alone should not be used as a guide for cancer management. Rather, physiologic function or existence of comorbid conditions should be major factors in determining treatment. As a result of the impending need for improved cancer management in older persons, a new subspecialty is evolving: geriatric oncology. This field stresses an important interaction between geriatricians and oncologists, development of research directed at the problems of cancer in older persons, and education at all levels with respect to cancer prevention, cancer detection, and cancer therapy. Physicians and oncologists need to be prepared for the projected increase of cancer in older persons.read more
Citations
More filters
Journal ArticleDOI
Issues of Aging and Geriatric Medicine: Relevance to Cancer Treatment and Hematopoietic Reconstitution
TL;DR: With appropriate pretreatment assessment of organ reserve, physical performance, and cognitive function, individualized (tailored) therapy may ultimately prove to offer the greatest chance for successful outcomes.
Journal ArticleDOI
Patterns-of-Care Analysis for Radiotherapy of Elderly Head-and-Neck Cancer Patients: A Trinational Survey in Germany, Austria and Switzerland
Erik Haehl,Alexander Rühle,Simon K. B. Spohn,Tanja Sprave,Eleni Gkika,Constantinos Zamboglou,Anca-Ligia Grosu,Nils H. Nicolay +7 more
TL;DR: Treatment of elderly HNSCC-patients in the German-speaking countries mainly follows guidelines established for younger patients, and algorithms for patient stratification and treatment de-escalation for “unfit” elderly patients are needed.
Journal ArticleDOI
Geriatric oncology and clinical trials.
TL;DR: For future clinical trials to be truly meaningful they need to appropriately assess and incorporate the needs of the majority of the cancer population, including changing eligibility criteria to make them less restrictive by accounting for multiple comorbidities and prior malignancy.
Journal ArticleDOI
Nuclear Transglutaminase 2 interacts with topoisomerase II⍺ to promote DNA damage repair in lung cancer cells
Xiao Lei,Kun Cao,Yuanyuan Chen,Hui Shen,Liu Zhe,Hongran Qin,Cai Jianming,Fu Gao,Yanyong Yang +8 more
TL;DR: Wang et al. as discussed by the authors discovered that Transglutaminase 2 (TG2) acted as a new component of DSB repair complex, which increased sensitivity in lung cancer cells and engrafted lung cancers.
Journal ArticleDOI
Rising to the medication's requirements: The experience of elderly cancer patients receiving palliative chemotherapy in the elective oncogeriatrics field.
TL;DR: Following an anthropological critical interpretative approach focusing on practical and symbolic effects of chemotherapy in a rapidly evolving medical field, 20 semi-structured interviews and observations of medicine storage places at home among elderly cancer patients aged 70 and over in a clearly incurable situation receiving palliative chemotherapy are conducted.
References
More filters
Journal ArticleDOI
Aging, natural death, and the compression of morbidity.
TL;DR: The average age at first infirmity can be raised, thereby making the morbidity curve more rectangular, and present data allow calculation of the ideal average life span, approximately 85 years.
Journal ArticleDOI
Health Care of the Elderly
TL;DR: The special considerations important to the proper evaluation of elderly patients are discussed, some current controversies in the field are highlighted, and recent progress in the management of several common clinical problems in the elderly are reviewed.
Journal ArticleDOI
Relationship between age at diagnosis and treatments received by cancer patients.
Vincent Mor,Susan Masterson-Allen,Richard J. Goldberg,Francis J. Cummings,Arvin S. Glicksman,Marsha D. Fretwell +5 more
TL;DR: Logistic regression analyses of subsamples of breast, lung, and colorectal cancer patients indicate that age is significantly inversely related to receipt of both subsequent chemotherapy and radiation therapy, controlling for stage of disease and presence of co‐morbid disease.
Journal ArticleDOI
Ovarian cancer in the elderly: an analysis of Surveillance, Epidemiology, and End Results Program data.
TL;DR: Aspects of ovarian cancer as it pertains especially to elderly women (those 65 years or older) are examined according to age/stage relationships at initial diagnosis and age variations in treatment and survival.
Journal ArticleDOI
Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderly.
TL;DR: Attenuated chemotherapy with lower doses of DAT is the preferred induction regimen for elderly patients with acute nonlymphocytic leukemia since it causes fewer early deaths, allows a better quality of life, and yields survival times as durable as intensive therapy.